Clinical Trial Update: Ig PRx in AECOPD: Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study of Ig PRx in acute exacerbation of chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ig PRx

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED